Statistics

Total Visits

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period35

File Visits

Downloads
35543-24.pdf42

Select a period of time:

Number of views in the range

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period19

Number of downloads in the range

Downloads
35543-24.pdf17

Views

Views
May 20245
June 20245
July 20241
August 20242
September 20243
October 20242
November 20241
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • May 2024
    1
  • June 2024
    4
  • July 2024
    6
  • August 2024
    1
  • September 2024
    0
  • October 2024
    3
  • November 2024
    2
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
United Kingdom1
 

Top countries by downloads

Downloads
United States15
 

Top cities views

Views
Chicago1
Fort Worth1
 

Top cities by downloads

Downloads
Fort Worth2